Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview.

Cancian M, Cosi E, Pizzi M, Giannini S, Bertozzi I, Fabris F, Randi ML.

Medicina (Kaunas). 2019 Aug 25;55(9). pii: E528. doi: 10.3390/medicina55090528.

2.

Contemporary management of essential thrombocythemia in children.

Randi ML, Bertozzi I, Putti MC.

Expert Rev Hematol. 2019 May;12(5):367-373. doi: 10.1080/17474086.2019.1602034. Epub 2019 Apr 27.

PMID:
30925843
3.

Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.

Di Pasquale I, Budde U, Tona F, Bertomoro A, Lombardi AM, Famoso G, Bertozzi I, Dittmer R, Schneppenheim S, Fabris F.

Thromb Res. 2019 Jan;173:42-47. doi: 10.1016/j.thromres.2018.11.005. Epub 2018 Nov 12.

PMID:
30471507
4.

Pregnancy outcome and management of 25 pregnancies in women with polycythemia vera.

Bertozzi I, Rumi E, Cavalloni C, Cazzola M, Fabris F, Randi ML.

Am J Hematol. 2018 Sep;93(9):E234-E235. doi: 10.1002/ajh.25210. Epub 2018 Aug 31. No abstract available.

5.

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.

De Stefano V, Rocca B, Tosetto A, Soldati D, Petrucci G, Beggiato E, Bertozzi I, Betti S, Carli G, Carpenedo M, Cattaneo D, Cavalca V, Dragani A, Elli E, Finazzi G, Iurlo A, Lanzarone G, Lissandrini L, Palandri F, Paoli C, Rambaldi A, Ranalli P, Randi ML, Ricco A, Rossi E, Ruggeri M, Specchia G, Timillero A, Turnu L, Vianelli N, Vannucchi AM, Rodeghiero F, Patrono C.

Blood Cancer J. 2018 Jun 1;8(6):49. doi: 10.1038/s41408-018-0078-3.

6.

Nasopharyngeal aspirate value in paediatric chronic lower respiratory tract illness.

Lunardi F, Vuljan SE, Perissinotto E, Pezzuto F, Malacrida S, Bugin S, Bertozzi I, Snijders D, Rizzo S, Barbato A, Calabrese F.

Eur Respir J. 2018 Jun 7;51(6). pii: 1701783. doi: 10.1183/13993003.01783-2017. Print 2018 Jun. No abstract available.

PMID:
29678943
7.

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.

8.

Thrombotic and hemorrhagic complications in idiopathic erythrocytosis.

Bertozzi I, Ruggeri M, Nichele I, Biagetti G, Cosi E, Randi ML.

Am J Hematol. 2017 Nov;92(11):E639-E641. doi: 10.1002/ajh.24873. Epub 2017 Aug 17. No abstract available.

9.

Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden.

Bertozzi I, Bogoni G, Biagetti G, Duner E, Lombardi AM, Fabris F, Randi ML.

Ann Hematol. 2017 Aug;96(8):1297-1302. doi: 10.1007/s00277-017-3040-8. Epub 2017 Jun 6.

PMID:
28585070
10.

Bone marrow histology for the diagnosis of essential thrombocythemia in children: a multicenter Italian study.

Putti MC, Pizzi M, Bertozzi I, Sabattini E, Micalizzi C, Farruggia P, Ramenghi U, Cesaro S, Russo G, Peroni E, Rugge M, Fabris F, Randi ML.

Blood. 2017 Jun 1;129(22):3040-3042. doi: 10.1182/blood-2017-01-761767. Epub 2017 Apr 13. No abstract available. Erratum in: Blood. 2017 Aug 17;130(7):954.

PMID:
28408463
11.

HFE mutations in idiopathic erythrocytosis.

Biagetti G, Catherwood M, Robson N, Bertozzi I, Cosi E, McMullin MF, Randi ML.

Br J Haematol. 2018 Apr;181(2):270-272. doi: 10.1111/bjh.14555. Epub 2017 Feb 7. No abstract available.

PMID:
28169423
12.

Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients.

Peroni E, Bertozzi I, Gherlinzoni F, Stefani PM, Lombardi A, Biagetti G, Fabris F, Randi ML.

Br J Haematol. 2018 Mar;180(6):908-911. doi: 10.1111/bjh.14486. Epub 2016 Dec 16. No abstract available.

PMID:
27982410
13.

Thrombotic risk correlates with mutational status in true essential thrombocythemia.

Bertozzi I, Peroni E, Coltro G, Bogoni G, Cosi E, Santarossa C, Fabris F, Randi ML.

Eur J Clin Invest. 2016 Aug;46(8):683-9. doi: 10.1111/eci.12647. Epub 2016 Jul 6.

PMID:
27271054
14.

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia.

Barbui T, Vannucchi AM, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Gisslinger H, Finazzi G, Carobbio A, Thiele J, Passamonti F, Falcone C, Tefferi A.

Blood Cancer J. 2015 Nov 27;5:e369. doi: 10.1038/bcj.2015.94. No abstract available.

15.

Idiopathic erythrocytosis: a study of a large cohort with a long follow-up.

Randi ML, Bertozzi I, Cosi E, Santarossa C, Peroni E, Fabris F.

Ann Hematol. 2016 Jan;95(2):233-7. doi: 10.1007/s00277-015-2548-z. Epub 2015 Nov 7.

PMID:
26547864
16.

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Rumi E, Bertozzi I, Casetti IC, Roncoroni E, Cavalloni C, Bellini M, Sant'Antonio E, Gotti M, Ferretti VV, Milanesi C, Peroni E, Pietra D, Astori C, Randi ML, Cazzola M; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators.

Haematologica. 2015 Nov;100(11):e443-5. doi: 10.3324/haematol.2015.131458. Epub 2015 Aug 6. No abstract available.

17.

Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: Is there evidence?

Snijders D, Fernandez Dominguez B, Calgaro S, Bertozzi I, Escribano Montaner A, Perilongo G, Barbato A.

Int J Immunopathol Pharmacol. 2015 Jun;28(2):150-9. doi: 10.1177/0394632015584724. Epub 2015 Jun 15. Review.

PMID:
26078380
18.

Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort.

Randi ML, Geranio G, Bertozzi I, Micalizzi C, Ramenghi U, Tucci F, Notarangelo LD, Ladogana S, Menna G, Giordano P, Consarino C, Farruggia P, Zanazzo GA, Fiori GM, Burnelli R, Russo G, Jankovich M, Peroni E, Duner E, Basso G, Fabris F, Putti MC.

Br J Haematol. 2015 May;169(4):584-9. doi: 10.1111/bjh.13329. Epub 2015 Feb 25.

PMID:
25716342
19.

Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.

Piccin A, Steurer M, Mitterer M, Blöchl EM, Marcheselli L, Pusceddu I, Marabese A, Bertozzi I, Corvetta D, Randi ML, Elli E, Pogliani EM, Veneri D, Perbellini O, Krampera M, Pacquola E, Gottardi M, Tiribelli M, Guella A, Innella B, Vivaldi P, De Biasi E, Sancetta R, Rocconi R, Bassan R, Gherlinzoni F, Pizzolo G, Gastl G, Cortelazzo S.

Intern Emerg Med. 2015 Jun;10(4):451-60. doi: 10.1007/s11739-015-1186-8. Epub 2015 Jan 14.

PMID:
25585678
20.

In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology.

Barbui T, Carobbio A, Rumi E, Finazzi G, Gisslinger H, Rodeghiero F, Randi ML, Rambaldi A, Gisslinger B, Pieri L, Bertozzi I, Casetti I, Pardanani A, Passamonti F, Vannucchi AM, Tefferi A.

Blood. 2014 Nov 6;124(19):3021-3. doi: 10.1182/blood-2014-07-591610. No abstract available.

PMID:
25377561
21.

A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.

Lussana F, Carobbio A, Randi ML, Elena C, Rumi E, Finazzi G, Bertozzi I, Pieri L, Ruggeri M, Palandri F, Polverelli N, Elli E, Tieghi A, Iurlo A, Ruella M, Cazzola M, Rambaldi A, Vannucchi AM, Barbui T.

Br J Haematol. 2014 Nov;167(4):541-6. doi: 10.1111/bjh.13080. Epub 2014 Aug 16.

PMID:
25130523
22.

Nasal NO, high-speed video microscopy, electron microscopy, and genetics: a primary ciliary dyskinesia puzzle to complete.

Snijders D, Bertozzi I, Barbato A.

Pediatr Res. 2014 Sep;76(3):321. doi: 10.1038/pr.2014.79. Epub 2014 Jun 16. No abstract available.

PMID:
24933010
23.

Effect of busulfan on JAK2V617F allele burden.

Randi ML, Santarossa C, Peroni E, Cosi E, Duner E, Bertozzi I, Fabris F.

Haematologica. 2014 Mar;99(3):e44. doi: 10.3324/haematol.2013.103051. Epub 2014 Jan 3. No abstract available.

24.

Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.

Randi ML, Bertozzi I, Rumi E, Elena C, Finazzi G, Vianelli N, Polverelli N, Ruggeri M, Vannucchi AM, Antonioli E, Lussana F, Tieghi A, Iurlo A, Elli E, Ruella M, Fabris F, Cazzola M, Barbui T.

Am J Hematol. 2014 Mar;89(3):306-9. doi: 10.1002/ajh.23635. Epub 2014 Feb 19.

25.

Bleeding manifestations apparently unrelated to coagulation or other organic disorders: A tentative classification and diagnostic clues.

Girolami A, Bertozzi I, Tasinato V, Sambado L, Treleani M.

Hematology. 2014 Jul;19(5):293-8. doi: 10.1179/1607845413Y.0000000133. Epub 2013 Nov 25.

PMID:
24164712
26.

Masked polycythemia vera (mPV): results of an international study.

Barbui T, Thiele J, Gisslinger H, Finazzi G, Carobbio A, Rumi E, Luigia Randi M, Bertozzi I, Vannucchi AM, Pieri L, Carrai V, Gisslinger B, Müllauer L, Ruggeri M, Rambaldi A, Tefferi A.

Am J Hematol. 2014 Jan;89(1):52-4. doi: 10.1002/ajh.23585. Epub 2013 Sep 19. Erratum in: Am J Hematol. 2018 May;93(5):E133.

27.

Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.

Snijders D, Calgaro S, Bertozzi I, Quartesan S, Kozuh I, Lunardi F, Barbato A.

Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):529-34. Review.

PMID:
23755770
28.

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.

Tefferi A, Rumi E, Finazzi G, Gisslinger H, Vannucchi AM, Rodeghiero F, Randi ML, Vaidya R, Cazzola M, Rambaldi A, Gisslinger B, Pieri L, Ruggeri M, Bertozzi I, Sulai NH, Casetti I, Carobbio A, Jeryczynski G, Larson DR, Müllauer L, Pardanani A, Thiele J, Passamonti F, Barbui T.

Leukemia. 2013 Sep;27(9):1874-81. doi: 10.1038/leu.2013.163. Epub 2013 Jun 6.

29.

Discrepant ratios of arterial versus venous thrombosis in hemophilia A as compared with hemophilia B.

Girolami A, Bertozzi I, de Marinis GB, Tasinato V, Sambado L.

J Thromb Thrombolysis. 2014 Apr;37(3):293-7. doi: 10.1007/s11239-013-0943-7.

PMID:
23681676
30.

Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency.

Girolami A, Berti de Marinis G, Bertozzi I, Peroni E, Tasinato V, Lombardi AM.

Eur J Haematol. 2013 Aug;91(2):152-6. doi: 10.1111/ejh.12129. Epub 2013 May 24.

PMID:
23621110
31.

Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).

Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Gisslinger H, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, Vannucchi AM, Tefferi A.

Blood. 2012 Dec 20;120(26):5128-33; quiz 5252. doi: 10.1182/blood-2012-07-444067. Epub 2012 Oct 1.

PMID:
23033268
32.

A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.

Passamonti F, Thiele J, Girodon F, Rumi E, Carobbio A, Gisslinger H, Kvasnicka HM, Ruggeri M, Randi ML, Gangat N, Vannucchi AM, Gianatti A, Gisslinger B, Müllauer L, Rodeghiero F, d'Amore ES, Bertozzi I, Hanson CA, Boveri E, Marino F, Maffioli M, Caramazza D, Antonioli E, Carrai V, Buxhofer-Ausch V, Pascutto C, Cazzola M, Barbui T, Tefferi A.

Blood. 2012 Aug 9;120(6):1197-201. doi: 10.1182/blood-2012-01-403279. Epub 2012 Jun 26.

PMID:
22740446
33.

Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

Barbui T, Thiele J, Carobbio A, Passamonti F, Rumi E, Randi ML, Bertozzi I, Vannucchi AM, Gisslinger H, Gisslinger B, Finazzi G, Ruggeri M, Rodeghiero F, Rambaldi A, Gangat N, Tefferi A.

Blood. 2012 Jul 19;120(3):569-71. doi: 10.1182/blood-2012-01-407981. Epub 2012 Jun 13.

PMID:
22700720
34.

Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: an international study of 264 patients.

Buxhofer-Ausch V, Gisslinger H, Thiele J, Gisslinger B, Kvasnicka HM, Müllauer L, Frantal S, Carobbio A, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Vannucchi AM, Antonioli E, Finazzi G, Gangat N, Tefferi A, Barbui T.

Am J Hematol. 2012 Jul;87(7):669-72. doi: 10.1002/ajh.23217. Epub 2012 May 10.

35.

Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.

Antonioli E, Guglielmelli P, Pieri L, Finazzi M, Rumi E, Martinelli V, Vianelli N, Luigia Randi M, Bertozzi I, De Stefano V, Za T, Rossi E, Ruggeri M, Elli E, Cacciola R, Cacciola E, Pogliani E, Rodeghiero F, Baccarani M, Passamonti F, Finazzi G, Rambaldi A, Bosi A, Cazzola M, Barbui T, Vannucchi AM; AGIMM Investigators.

Am J Hematol. 2012 May;87(5):552-4. doi: 10.1002/ajh.23160. Epub 2012 Apr 4.

36.

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome.

Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Randi ML, Bertozzi I, Marino F, Vannucchi AM, Pieri L, Rotunno G, Gisslinger H, Gisslinger B, Müllauer L, Finazzi G, Carobbio A, Gianatti A, Ruggeri M, Nichele I, D'Amore E, Rambaldi A, Tefferi A.

Blood. 2012 Mar 8;119(10):2239-41. doi: 10.1182/blood-2011-11-393819. Epub 2012 Jan 13.

PMID:
22246040
37.

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.

Carobbio A, Finazzi G, Thiele J, Kvasnicka HM, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Luigia Randi M, Bertozzi I, Vannucchi AM, Antonioli E, Gisslinger H, Buxhofer-Ausch V, Gangat N, Rambaldi A, Tefferi A, Barbui T.

Am J Hematol. 2012 Feb;87(2):203-4. doi: 10.1002/ajh.22241. Epub 2012 Jan 11.

38.

A 40-year-old man with recurrent fainting, hypotension, lower limb edema and oliguria with body weight gain and secondary erythrocytosis.

Berti de Marinis G, Bertozzi I, Allemand E, Tezza F, Randi ML, Naso A, Fabris F.

Intern Emerg Med. 2012 Oct;7(5):453-6. Epub 2011 Sep 25. No abstract available.

PMID:
21948352
39.

Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria.

Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Vannucchi AM, Antonioli E, Gisslinger H, Buxhofer-Ausch V, Gangat N, Rambaldi A, Tefferi A, Barbui T.

Leukemia. 2012 Apr;26(4):716-9. doi: 10.1038/leu.2011.258. Epub 2011 Sep 16.

PMID:
21926959
40.

Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.

Girolami A, Bertozzi I, de Marinis GB, Bonamigo E, Fabris F.

Hematology. 2011 Sep;16(5):308-12. doi: 10.1179/102453311X13085644680069.

PMID:
21902896
41.

Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.

Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M, Rodeghiero F, d'Amore ES, Randi ML, Bertozzi I, Marino F, Vannucchi AM, Antonioli E, Carrai V, Gisslinger H, Buxhofer-Ausch V, Müllauer L, Carobbio A, Gianatti A, Gangat N, Hanson CA, Tefferi A.

J Clin Oncol. 2011 Aug 10;29(23):3179-84. doi: 10.1200/JCO.2010.34.5298. Epub 2011 Jul 11.

PMID:
21747083
42.

Congenital FVII deficiency and thrombotic events after replacement therapy.

Girolami A, Bertozzi I, Rigoni I, Muzzolon R, Vettore S.

J Thromb Thrombolysis. 2011 Oct;32(3):362-7. doi: 10.1007/s11239-011-0603-8. Review.

PMID:
21681394
43.

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Vannucchi AM, Antonioli E, Gisslinger H, Buxhofer-Ausch V, Finazzi G, Gangat N, Tefferi A, Barbui T.

Blood. 2011 Jun 2;117(22):5857-9. doi: 10.1182/blood-2011-02-339002. Epub 2011 Apr 13.

PMID:
21490340
44.

Thrombotic events in patients with congenital prekallikrein deficiency: a critical evaluation of all reported cases.

Girolami A, Allemand E, Bertozzi I, Candeo N, Marun S, Girolami B.

Acta Haematol. 2010;123(4):210-4. doi: 10.1159/000313361. Epub 2010 Apr 27.

PMID:
20424433

Supplemental Content

Loading ...
Support Center